227 related articles for article (PubMed ID: 21911653)
1. Blockade of prolymphangiogenic vascular endothelial growth factor C in dry eye disease.
Goyal S; Chauhan SK; Dana R
Arch Ophthalmol; 2012 Jan; 130(1):84-9. PubMed ID: 21911653
[TBL] [Abstract][Full Text] [Related]
2. Evidence of corneal lymphangiogenesis in dry eye disease: a potential link to adaptive immunity?
Goyal S; Chauhan SK; El Annan J; Nallasamy N; Zhang Q; Dana R
Arch Ophthalmol; 2010 Jul; 128(7):819-24. PubMed ID: 20625040
[TBL] [Abstract][Full Text] [Related]
3. Amelioration of murine dry eye disease by topical antagonist to chemokine receptor 2.
Goyal S; Chauhan SK; Zhang Q; Dana R
Arch Ophthalmol; 2009 Jul; 127(7):882-7. PubMed ID: 19597109
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic efficacy of topical epigallocatechin gallate in murine dry eye.
Lee HS; Chauhan SK; Okanobo A; Nallasamy N; Dana R
Cornea; 2011 Dec; 30(12):1465-72. PubMed ID: 21993466
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of topical blockade of interleukin-1 in experimental dry eye disease.
Okanobo A; Chauhan SK; Dastjerdi MH; Kodati S; Dana R
Am J Ophthalmol; 2012 Jul; 154(1):63-71. PubMed ID: 22541929
[TBL] [Abstract][Full Text] [Related]
6. b-FGF induces corneal blood and lymphatic vessel growth in a spatially distinct pattern.
Hajrasouliha AR; Sadrai Z; Chauhan SK; Dana R
Cornea; 2012 Jul; 31(7):804-9. PubMed ID: 22467003
[TBL] [Abstract][Full Text] [Related]
7. Sunitinib inhibits inflammatory corneal lymphangiogenesis.
Detry B; Blacher S; Erpicum C; Paupert J; Maertens L; Maillard C; Munaut C; Sounni NE; Lambert V; Foidart JM; Rakic JM; Cataldo D; Noël A
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3082-93. PubMed ID: 23580490
[TBL] [Abstract][Full Text] [Related]
8. Orbital Angiogenesis and Lymphangiogenesis in Thyroid Eye Disease: An Analysis of Vascular Growth Factors with Clinical Correlation.
Wong LL; Lee NG; Amarnani D; Choi CJ; Bielenberg DR; Freitag SK; D'Amore PA; Kim LA
Ophthalmology; 2016 Sep; 123(9):2028-36. PubMed ID: 27423310
[TBL] [Abstract][Full Text] [Related]
9. Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer.
Yang H; Kim C; Kim MJ; Schwendener RA; Alitalo K; Heston W; Kim I; Kim WJ; Koh GY
Mol Cancer; 2011 Apr; 10():36. PubMed ID: 21481239
[TBL] [Abstract][Full Text] [Related]
10. Involvement of corneal lymphangiogenesis in a mouse model of allergic eye disease.
Lee HS; Hos D; Blanco T; Bock F; Reyes NJ; Mathew R; Cursiefen C; Dana R; Saban DR
Invest Ophthalmol Vis Sci; 2015 May; 56(5):3140-8. PubMed ID: 26024097
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of lymphangiogenesis and lymphatic drainage via vascular endothelial growth factor receptor 3 blockade increases the severity of inflammation in a mouse model of chronic inflammatory arthritis.
Guo R; Zhou Q; Proulx ST; Wood R; Ji RC; Ritchlin CT; Pytowski B; Zhu Z; Wang YJ; Schwarz EM; Xing L
Arthritis Rheum; 2009 Sep; 60(9):2666-76. PubMed ID: 19714652
[TBL] [Abstract][Full Text] [Related]
12. Dry eye predisposes to corneal neovascularization and lymphangiogenesis after corneal injury in a murine model.
Cho YK; Archer B; Ambati BK
Cornea; 2014 Jun; 33(6):621-7. PubMed ID: 24727637
[TBL] [Abstract][Full Text] [Related]
13. Blockade of VEGFR3-signalling specifically inhibits lymphangiogenesis in inflammatory corneal neovascularisation.
Bock F; Onderka J; Dietrich T; Bachmann B; Pytowski B; Cursiefen C
Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):115-9. PubMed ID: 17909835
[TBL] [Abstract][Full Text] [Related]
14. Short- and long-term corneal vascular effects of tafluprost eye drops.
Hos D; Koch KR; Bock F; Grajewski RS; Dietlein TS; Cursiefen C; Heindl LM
Graefes Arch Clin Exp Ophthalmol; 2013 Aug; 251(8):1919-27. PubMed ID: 23624591
[TBL] [Abstract][Full Text] [Related]
15. Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution.
Kataru RP; Jung K; Jang C; Yang H; Schwendener RA; Baik JE; Han SH; Alitalo K; Koh GY
Blood; 2009 May; 113(22):5650-9. PubMed ID: 19346498
[TBL] [Abstract][Full Text] [Related]
16. Features of corneal neovascularization and lymphangiogenesis induced by different etiological factors in mice.
Shi W; Ming C; Liu J; Wang T; Gao H
Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):55-67. PubMed ID: 20640436
[TBL] [Abstract][Full Text] [Related]
17. Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues.
Lohela M; Heloterä H; Haiko P; Dumont DJ; Alitalo K
Am J Pathol; 2008 Dec; 173(6):1891-901. PubMed ID: 18988807
[TBL] [Abstract][Full Text] [Related]
18. Topical omega-3 and omega-6 fatty acids for treatment of dry eye.
Rashid S; Jin Y; Ecoiffier T; Barabino S; Schaumberg DA; Dana MR
Arch Ophthalmol; 2008 Feb; 126(2):219-25. PubMed ID: 18268213
[TBL] [Abstract][Full Text] [Related]
19. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
Davydova N; Harris NC; Roufail S; Paquet-Fifield S; Ishaq M; Streltsov VA; Williams SP; Karnezis T; Stacker SA; Achen MG
J Biol Chem; 2016 Dec; 291(53):27265-27278. PubMed ID: 27852824
[TBL] [Abstract][Full Text] [Related]
20. Soluble vascular endothelial growth factor receptor-3 suppresses allosensitization and promotes corneal allograft survival.
Emami-Naeini P; Dohlman TH; Omoto M; Hattori T; Chen Y; Lee HS; Chauhan SK; Dana R
Graefes Arch Clin Exp Ophthalmol; 2014 Nov; 252(11):1755-62. PubMed ID: 25091513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]